Skip to main content
. Author manuscript; available in PMC: 2019 Sep 30.
Published in final edited form as: ACS Biomater Sci Eng. 2018 Nov 4;4(12):4354–4366. doi: 10.1021/acsbiomaterials.8b01142

Figure 3.

Figure 3.

Stage-dependent impact of ECMs on neural tissue patterning of hiPSCs. The cells treated with ECMs at both day 8 and day 16 were compared for forebrain and hindbrain marker expression. (A) Quantification of marker expression using the ImageJ software for immunostaining images (n = 3). (B) Flow cytometry analysis of forebrain markers (TBR1, PROX1) and hindbrain markers (HOXB4, ISL1) at day 21 (n = 3). *, **, and # indicate p < 0.05 (two-way ANOVA, see Supporting Information Table S3).